A randomized, double blind, placebo controlled, parallel groups, pilot study to assess the effects of two new nail lacquers, cyclosporine 5% and calcipotriol 0.005%, in the treatment of nail psoriasis

Trial Profile

A randomized, double blind, placebo controlled, parallel groups, pilot study to assess the effects of two new nail lacquers, cyclosporine 5% and calcipotriol 0.005%, in the treatment of nail psoriasis

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Mar 2016

At a glance

  • Drugs Calcipotriol (Primary) ; Ciclosporin (Primary)
  • Indications Psoriasis
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Sponsors Polichem
  • Most Recent Events

    • 08 Mar 2016 Primary endpoint has been met. (Nail Psoriasis Severity Index score)
    • 08 Mar 2016 Results presented at the 74th Annual Meeting of the American Academy of Dermatology
    • 01 Jun 2013 Planned End Date changed from 27 Oct 2011 to 1 Mar 2013 as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top